150 related articles for article (PubMed ID: 28820396)
1. The role of mTOR inhibitors and HMG-CoA reductase inhibitors on young and old endothelial cell functions, critical for re-endothelialisation after percutaneous coronary intervention: an in vitro study.
Korybalska K; Kawka E; Breborowicz A; Witowski J
J Physiol Pharmacol; 2017 Jun; 68(3):397-405. PubMed ID: 28820396
[TBL] [Abstract][Full Text] [Related]
2. Atorvastatin does not impair endothelial cell wound healing in an in vitro model of vascular injury.
Korybalska K; Kawka E; Breborowicz A; Witowski J
J Physiol Pharmacol; 2012 Aug; 63(4):389-95. PubMed ID: 23070088
[TBL] [Abstract][Full Text] [Related]
3. Effect of High Dose Statin Pretreatment on Endothelial Progenitor Cells After Percutaneous Coronary Intervention (HIPOCRATES Study).
Eisen A; Leshem-Lev D; Yavin H; Orvin K; Mager A; Rechavia E; Bental T; Dadush O; Battler A; Kornowski R; Lev EI
Cardiovasc Drugs Ther; 2015 Apr; 29(2):129-35. PubMed ID: 25712416
[TBL] [Abstract][Full Text] [Related]
4. Lysophosphatidic acid pretreatment prevents micromolar atorvastatin-induced endothelial cell death and ensures the beneficial effects of high-concentration statin therapy on endothelial gene expression.
Garrido JM; Esteban M; Roda O; Alaminos M; Sánchez-Montesinos I
Ann Vasc Surg; 2012 May; 26(4):549-58. PubMed ID: 22520393
[TBL] [Abstract][Full Text] [Related]
5. Effect of atorvastatin on wound healing in rats.
Suzuki-Banhesse VF; Azevedo FF; Araujo EP; do Amaral ME; Caricilli AM; Saad MJ; Lima MH
Biol Res Nurs; 2015 Mar; 17(2):159-68. PubMed ID: 24924353
[TBL] [Abstract][Full Text] [Related]
6. The dual targeting of insulin and insulin-like growth factor 1 receptor enhances the mTOR inhibitor-mediated antitumor efficacy in hepatocellular carcinoma.
Pivonello C; Negri M; De Martino MC; Napolitano M; de Angelis C; Provvisiero DP; Cuomo G; Auriemma RS; Simeoli C; Izzo F; Colao A; Hofland LJ; Pivonello R
Oncotarget; 2016 Mar; 7(9):9718-31. PubMed ID: 26756219
[TBL] [Abstract][Full Text] [Related]
7. The Antiangiogenesis Effect of Pirfenidone in Wound Healing In Vitro.
Liu X; Yang Y; Guo X; Liu L; Wu K; Yu M
J Ocul Pharmacol Ther; 2017 Nov; 33(9):693-703. PubMed ID: 28933986
[TBL] [Abstract][Full Text] [Related]
8. Exosomes secreted from mesenchymal stem cells mediate the regeneration of endothelial cells treated with rapamycin by delivering pro-angiogenic microRNAs.
Wang W; Zhao Y; Li H; Zhang Y; Jia X; Wang C; Zhu P; Wang J; Hou Y
Exp Cell Res; 2021 Feb; 399(1):112449. PubMed ID: 33347856
[TBL] [Abstract][Full Text] [Related]
9. The mTOR/AP-1/VEGF signaling pathway regulates vascular endothelial cell growth.
Wang S; Lu J; You Q; Huang H; Chen Y; Liu K
Oncotarget; 2016 Aug; 7(33):53269-53276. PubMed ID: 27458160
[TBL] [Abstract][Full Text] [Related]
10. Effects of atorvastatin on fine particle-induced inflammatory response, oxidative stress and endothelial function in human umbilical vein endothelial cells.
Zhao J; Xie Y; Jiang R; Kan H; Song W
Hum Exp Toxicol; 2011 Nov; 30(11):1828-39. PubMed ID: 21357632
[TBL] [Abstract][Full Text] [Related]
11. Pro-angiogenic activity of notoginsenoside R1 in human umbilical vein endothelial cells in vitro and in a chemical-induced blood vessel loss model of zebrafish in vivo.
Yang BR; Hong SJ; Lee SM; Cong WH; Wan JB; Zhang ZR; Zhang QW; Zhang Y; Wang YT; Lin ZX
Chin J Integr Med; 2016 Jun; 22(6):420-9. PubMed ID: 25533511
[TBL] [Abstract][Full Text] [Related]
12. Everolimus inhibits anti-HLA I antibody-mediated endothelial cell signaling, migration and proliferation more potently than sirolimus.
Jin YP; Valenzuela NM; Ziegler ME; Rozengurt E; Reed EF
Am J Transplant; 2014 Apr; 14(4):806-19. PubMed ID: 24580843
[TBL] [Abstract][Full Text] [Related]
13. The inhibition of MAPK potentiates the anti-angiogenic efficacy of mTOR inhibitors.
Dormond-Meuwly A; Roulin D; Dufour M; Benoit M; Demartines N; Dormond O
Biochem Biophys Res Commun; 2011 Apr; 407(4):714-9. PubMed ID: 21439267
[TBL] [Abstract][Full Text] [Related]
14. Anti-tumor effect of the mammalian target of rapamycin inhibitor everolimus in oral squamous cell carcinoma.
Naruse T; Yanamoto S; Yamada S; Rokutanda S; Kawakita A; Kawasaki G; Umeda M
Pathol Oncol Res; 2015 Jul; 21(3):765-73. PubMed ID: 25682238
[TBL] [Abstract][Full Text] [Related]
15. Anti-angiogenic effect of furanodiene on HUVECs in vitro and on zebrafish in vivo.
Zhong ZF; Hoi PM; Wu GS; Xu ZT; Tan W; Chen XP; Cui L; Wu T; Wang YT
J Ethnopharmacol; 2012 Jun; 141(2):721-7. PubMed ID: 21911050
[TBL] [Abstract][Full Text] [Related]
16. Atorvastatin reduces long pentraxin 3 expression in vascular cells by inhibiting protein geranylgeranylation.
Baetta R; Lento S; Ghilardi S; Barbati E; Corsini A; Tremoli E; Banfi C
Vascul Pharmacol; 2015; 67-69():38-47. PubMed ID: 25849951
[TBL] [Abstract][Full Text] [Related]
17. Davallia bilabiata exhibits anti-angiogenic effect with modified MMP-2/TIMP-2 secretion and inhibited VEGF ligand/receptors expression in vascular endothelial cells.
Liu CT; Bi KW; Huang CC; Wu HT; Ho HY; S Pang JH; Huang ST
J Ethnopharmacol; 2017 Jan; 196():213-224. PubMed ID: 27993633
[TBL] [Abstract][Full Text] [Related]
18. mTOR inhibition: a promising strategy for stabilization of atherosclerotic plaques.
Martinet W; De Loof H; De Meyer GRY
Atherosclerosis; 2014 Apr; 233(2):601-607. PubMed ID: 24534455
[TBL] [Abstract][Full Text] [Related]
19. Statins, HMG-CoA Reductase Inhibitors, Improve Neovascularization by Increasing the Expression Density of CXCR4 in Endothelial Progenitor Cells.
Chiang KH; Cheng WL; Shih CM; Lin YW; Tsao NW; Kao YT; Lin CT; Wu SC; Huang CY; Lin FY
PLoS One; 2015; 10(8):e0136405. PubMed ID: 26309120
[TBL] [Abstract][Full Text] [Related]
20. Atorvastatin affects several angiogenic mediators in human endothelial cells.
Dulak J; Loboda A; Jazwa A; Zagorska A; Dörler J; Alber H; Dichtl W; Weidinger F; Frick M; Jozkowicz A
Endothelium; 2005; 12(5-6):233-41. PubMed ID: 16410222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
